Semax: 30mg
Brain + moodDescription
Semax is a synthetic heptapeptide (met-glu-his-phe-pro-gly-pro) derived from acth (adrenocorticotropic hormone). it was developed in russia in the 1980s and has been approved there as a pharmaceutical for stroke, cognitive decline, and attention deficit disorders. its primary mechanism is stimulation of bdnf (brain-derived neurotrophic factor) release, a key protein for neuroplasticity — the brain's ability to form new neural connections, adapt to learning, and recover from injury. semax also increases cerebral blood flow, enhances dopamine and serotonin turnover, and modulates the expression of genes involved in neurogenesis. research has shown it may improve working memory, attention, and processing speed. its neuroprotective effects have been studied in ischemic stroke and traumatic brain injury models. semax is considered a nootropic and neuroprotective peptide with some of the strongest clinical backing in the brain peptide category due to its russian pharmaceutical history. for research and educational purposes only.
Specifications
| Amount in Vial | 30mg |
|---|---|
| BAC Water | 3ml |
| Amount per Unit | 0.1mg per unit |
| Recommended Dose | 500mcg to 1000mcg (5 to 10 units) |
| Frequency | Daily |
| Injection Type | Subcutaneous |
Dose Calculator
Based on 0.1mg per unit (100-unit insulin syringe)
Quick Reference
Reconstitution
Vial size: 30mg
Add BAC water: 3ml
Concentration: 0.1mg per unit
For research and educational use only.
This page provides research dosing information only. Not intended as medical advice. Consult a qualified professional before any use.